Pharmaceutical Biotechnology

May 13-14, 2019 | France

Implementing a global platform to explore and enhance the future of Medicine and pharmaceutical Biotechnology. Euro pharmaceutical Biotechnology 2019 welcomes all the participants to attend the 24th International Meet on Pharmaceutical Biotechnology which will be held during May 13-14, 2019, Paris, France. The primary theme of the conference is “Providing a global platform to explore and enhance the future of medicine and pharmaceutical biotechnology”. This conference provides a platform for all the meeting professionals, young and experienced researchers, academicians, business delegates all over the world

Spotlight

When it comes to enlisting the cancer-fighting potential of the body’s immune defenses, Amgen believes versatility is a virtue. Dave Reese discusses Amgen’s growing cancer immunotherapy research capabilities. Large numbers of immune cells (T cells in particular) are frequently found within or adjacent to melanoma tumors, indicating that the tumors attract the attention—if not the action—of the immune system. True to its reputation as one of the most ‘immunogenic‘ cancers, melanoma now has more U.S. Food and Drug Administration (FDA)-approved immunotherapy (immune system-targeting) drugs than any other cancer type. As a consequence, metastatic melanoma is no longer the universally fatal disease it was even just 3 or 4 years ago.


OTHER PAST CONFERENCES

Pre-Filled Syringes & Auto-Injectors Forum 2022

December 1-2, 2022 | USA

Projected to hit $8 billion by the end of 2024 in the US alone, the market for pre-filled syringes and auto-injectors continues to expand at an impressive rate. Numerous advantages such as ease of administration, enhanced safety, reduced risk of contamination, and accuracy of dosing, have made PFS & auto-injectors attractive over other delivery systems.

MEDICINE. MEDTECH. PHARMACY. DENTISTRY 2022

September 28-October 7, 2022 | USA

Learn from experts, leaders, & fresh new voices, so you can stay ahead of pharma trends.

The 2nd Saudi International Pharma Expo

November 7-9, 2022 | Saudi Arabia

SIPE 2022 will provide an opportunity for the participating companies to display their products & services to the gamut of visitors ; globally from pharma and healthcare industries. The 2-day expo will bring together eminent personalities from various sectors of pharma; non-pharma and healthcare industries. SIPE 2022 is aimed at bringing together all the pharma professionals under one roof; the pharmaceutical exhibition focuses on knowledge, technology and business development.

iPharma Expo 2022

October 20-21, 2022 | USA

After a series of many successful pharma and medical conferences and expos for the past many years, we are happy to announce the International Pharmaceutical Business Expo, iPharma Expo 2022 at Boston, USA during October 20- 21, 2022.

Spotlight

When it comes to enlisting the cancer-fighting potential of the body’s immune defenses, Amgen believes versatility is a virtue. Dave Reese discusses Amgen’s growing cancer immunotherapy research capabilities. Large numbers of immune cells (T cells in particular) are frequently found within or adjacent to melanoma tumors, indicating that the tumors attract the attention—if not the action—of the immune system. True to its reputation as one of the most ‘immunogenic‘ cancers, melanoma now has more U.S. Food and Drug Administration (FDA)-approved immunotherapy (immune system-targeting) drugs than any other cancer type. As a consequence, metastatic melanoma is no longer the universally fatal disease it was even just 3 or 4 years ago.

resources